MCM3APAS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.401600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.422600E-01
Normal-vs-Stage2
6.256200E-01
Normal-vs-Stage3
3.507800E-01
Normal-vs-Stage4
9.779000E-01
Stage1-vs-Stage2
4.440400E-02
Stage1-vs-Stage3
6.359600E-03
Stage1-vs-Stage4
9.511000E-01
Stage2-vs-Stage3
1.92250000030647E-07
Stage2-vs-Stage4
1.161820E-01
Stage3-vs-Stage4
5.558100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.551200E-01
Normal-vs-AfricanAmerican
5.449000E-01
Normal-vs-Asian
4.975000E-01
Caucasian-vs-AfricanAmerican
9.478000E-01
Caucasian-vs-Asian
1.970990E-01
AfricanAmerican-vs-Asian
4.153600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.501400E-01
Normal-vs-Female
6.287200E-01
Male-vs-Female
7.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.786200E-01
Normal-vs-Age(41-60Yrs)
6.452400E-01
Normal-vs-Age(61-80Yrs)
6.308800E-01
Normal-vs-Age(81-100Yrs)
6.560400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.968400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.393200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.811400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.481200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.586200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.846000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.132400E-01
Normal-vs-Daily Drinker
5.239000E-01
Normal-vs-Weekly Drinker
7.434200E-01
Normal-vs-Occasional Drinker
4.462800E-01
Normal-vs-Social Drinker
7.602200E-01
Non Drinker-vs-Daily Drinker
3.104400E-01
Non Drinker-vs-Weekly Drinker
4.244800E-01
Non Drinker-vs-Occasional Drinker
6.243600E-01
Non Drinker-vs-Social Drinker
2.230800E-01
Daily Drinker-vs-Weekly Drinker
2.228000E-01
Daily Drinker-vs-Occasional Drinker
2.492600E-01
Daily Drinker-vs-Social Drinker
6.187800E-02
Weekly Drinker-vs-Occasional Drinker
6.174800E-01
Weekly Drinker-vs-Social Drinker
8.780800E-01
Occasional Drinker-vs-Social Drinker
6.285800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.994600E-01
Normal-vs-Grade 2
1.825640E-01
Normal-vs-Grade 3
1.735450E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.717800E-01
Grade 1-vs-Grade 3
3.688000E-01
Grade 1-vs-Grade 4
2.994600E-01
Grade 2-vs-Grade 3
1.526400E-01
Grade 2-vs-Grade 4
1.825640E-01
Grade 3-vs-Grade 4
1.735450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.901200E-01
Normal-vs-NonDiabetic
6.347000E-01
Diabetic-vs-NonDiabetic
7.914400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.459800E-01
Normal-vs-NoPancreatitis
6.157200E-01
Pancreatitis-vs-NoPancreatitis
5.611500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.834800E-01
Normal-vs-N1
6.213000E-01
N0-vs-N1
4.188400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.018000E-01
Normal-vs-TP53-NonMutant
6.881200E-01
TP53-Mutant-vs-TP53-NonMutant
7.930400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
